Cure8 news brief
Why This Matters
Recognition of a local IBD leader signals available specialized multidisciplinary care and ongoing clinical trials activity at UCI Health — relevant for patients seeking advanced treatment or trial participation. It also highlights mentorship and programs that may improve future IBD care and outreach.
Who Should Pay Attention
Adults with Crohn’s disease or ulcerative colitis in Orange and Los Angeles counties; patients seeking multidisciplinary IBD care or clinical trials; gastroenterology clinicians and IBD researchers; caregivers looking for specialized centers.
Study Snapshot
What To Know
Dr. Parekh leads a multidisciplinary IBD program at UCI Health and was honored by the Crohn’s & Colitis Foundation’s Los Angeles and Orange County chapters for medical excellence. The write-up emphasizes her clinical care, mentorship, and program-building within an academic health system.
The piece notes her research interests include outcomes in Crohn’s disease and ulcerative colitis, clinical trials for new drug therapies, women’s health, and ethnicity’s role in disease outcomes. It does not report specific study results or name particular drugs or trials.
The article is a local news/awards story rather than a research report; contact information is provided for patients seeking care.
Keep In Mind
This is a local news/award announcement, not a research paper. The article describes research interests and clinical trials involvement but does not present study data, trial names, or specific therapies. For care or trial enrollment, contact the UCI Health IBD Program directly.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.